Interdisciplinary approach to multiple myeloma - time to diagnosis and warning signs.


Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 24 11 2020
medline: 1 5 2021
entrez: 23 11 2020
Statut: ppublish

Résumé

Delayed diagnosis is a common challenge in the management of multiple myeloma (MM). This prospective interdisciplinary study evaluated symptoms and time to diagnosis (TTD) in 81/295 screened patients at our tertiary center, who were examined by an orthopedist prior to the MM diagnosis. The most frequent complaint was back pain (81%), mainly localized thoracic and/or lumbar. Pain was independent of movement in 85%, occurred at night in 69%, and at multiple localizations in 30% of patients. Notably, 63% patients with an orthopedic disease noticed substantial symptom change before the MM diagnosis was made. The median TTD was 7 months and did not differ significantly between patients with or without a preexisting skeletal disease. To avoid delayed diagnosis, physicians should consider MM as a differential diagnosis, whenever warning signs such as skeletal pain independent from movement, at night, at various localizations, and change in pain characteristics accompanied by fatigue, are reported.

Identifiants

pubmed: 33225781
doi: 10.1080/10428194.2020.1849681
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

891-898

Auteurs

Georg W Herget (GW)

Department of Orthopedics and Trauma Surgery, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Felix Kälberer (F)

Department of Orthopedics and Trauma Surgery, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Gabriele Ihorst (G)

Clinical Trials Unit, Medical Clinic, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Giulia Graziani (G)

Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
Department of Medicine, Hematology and Oncology, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Lukas Klein (L)

Department of Orthopedics and Trauma Surgery, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Michael Rassner (M)

Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
Department of Medicine, Hematology and Oncology, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Christian Gehler (C)

Department of Orthopedics and Trauma Surgery, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Johannes Jung (J)

Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
Department of Medicine, Hematology and Oncology, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Hagen Schmal (H)

Department of Orthopedics and Trauma Surgery, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
Department of Orthopaedics and Traumatology, Odense University Hospital, Odense, Denmark.
Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Ralph Wäsch (R)

Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
Department of Medicine, Hematology and Oncology, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Monika Engelhardt (M)

Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
Department of Medicine, Hematology and Oncology, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH